Su Zhou Gong Ye Yuan Qu Guan Wei Hui - Net Worth and Insider Trading

Su Zhou Gong Ye Yuan Qu Guan Wei Hui Net Worth

The estimated net worth of Su Zhou Gong Ye Yuan Qu Guan Wei Hui is at least $215 Million dollars as of 2025-04-26. Su Zhou Gong Ye Yuan Qu Guan Wei Hui is the 2201 Interest of corporation controlled by you of CStone Pharmaceuticals and owns about 75,553,730 shares of CStone Pharmaceuticals (HKSE:02616) stock worth over $215 Million. Details can be seen in Su Zhou Gong Ye Yuan Qu Guan Wei Hui's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Su Zhou Gong Ye Yuan Qu Guan Wei Hui has not made any transactions after 2023-07-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Su Zhou Gong Ye Yuan Qu Guan Wei Hui

Su Zhou Gong Ye Yuan Qu Guan Wei Hui Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Su Zhou Gong Ye Yuan Qu Guan Wei Hui owns 1 companies in total, including CStone Pharmaceuticals (HKSE:02616) .

Click here to see the complete history of Su Zhou Gong Ye Yuan Qu Guan Wei Hui’s form 4 insider trades.

Insider Ownership Summary of Su Zhou Gong Ye Yuan Qu Guan Wei Hui

Ticker	Company	Transaction Date	Type of Owner
HKSE:02616	CStone Pharmaceuticals	2023-07-13	2201 Interest of corporation controlled by you

Su Zhou Gong Ye Yuan Qu Guan Wei Hui Latest Holdings Summary

Su Zhou Gong Ye Yuan Qu Guan Wei Hui currently owns a total of 1 stock. Su Zhou Gong Ye Yuan Qu Guan Wei Hui owns 75,553,730 shares of CStone Pharmaceuticals (HKSE:02616) as of July 13, 2023, with a value of $215 Million.

Latest Holdings of Su Zhou Gong Ye Yuan Qu Guan Wei Hui

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02616	CStone Pharmaceuticals	2023-07-13	75,553,730	2.85	215,328,131

Holding Weightings of Su Zhou Gong Ye Yuan Qu Guan Wei Hui

Su Zhou Gong Ye Yuan Qu Guan Wei Hui Form 4 Trading Tracker

According to the SEC Form 4 filings, Su Zhou Gong Ye Yuan Qu Guan Wei Hui has made a total of 4 transactions in CStone Pharmaceuticals (HKSE:02616) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in CStone Pharmaceuticals is the sale of 3,712,914 shares on July 13, 2023, which brought Su Zhou Gong Ye Yuan Qu Guan Wei Hui around $9 Million.

Insider Trading History of Su Zhou Gong Ye Yuan Qu Guan Wei Hui

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Su Zhou Gong Ye Yuan Qu Guan Wei Hui Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Su Zhou Gong Ye Yuan Qu Guan Wei Hui Ownership Network

Ownership Network List of Su Zhou Gong Ye Yuan Qu Guan Wei Hui

No Data

Ownership Network Relation of Su Zhou Gong Ye Yuan Qu Guan Wei Hui

Su Zhou Gong Ye Yuan Qu Guan Wei Hui Owned Company Details

What does CStone Pharmaceuticals do?

Who are the key executives at CStone Pharmaceuticals?

Su Zhou Gong Ye Yuan Qu Guan Wei Hui is the 2201 Interest of corporation controlled by you of CStone Pharmaceuticals. Other key executives at CStone Pharmaceuticals include 2201 Interest of corporation controlled by you Pfizer Inc. , 2101 Beneficial owner Yang Jianxin , and 2201 Interest of corporation controlled by you Boyu Capital Fund II, L.P. .

CStone Pharmaceuticals (HKSE:02616) Insider Trades Summary

Over the past 18 months, Su Zhou Gong Ye Yuan Qu Guan Wei Hui made no insider transaction in CStone Pharmaceuticals (HKSE:02616). Other recent insider transactions involving CStone Pharmaceuticals (HKSE:02616) include a net purchase of 760,500 shares made by Yang Jianxin , a net sale of 0 shares made by Morgan Stanley , and a net sale of 0 shares made by Boyu Capital Holdings Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of CStone Pharmaceuticals (HKSE:02616) in total and bought 560,000 shares, with a net purchase of 560,000 shares. During the past 18 months, 149,500 shares of CStone Pharmaceuticals (HKSE:02616) were sold and 910,000 shares were bought by its insiders, resulting in a net purchase of 760,500 shares.

CStone Pharmaceuticals (HKSE:02616)'s detailed insider trading history can be found in Insider Trading Tracker table.

CStone Pharmaceuticals Insider Transactions

No Available Data

Su Zhou Gong Ye Yuan Qu Guan Wei Hui Mailing Address

Above is the net worth, insider trading, and ownership report for Su Zhou Gong Ye Yuan Qu Guan Wei Hui. Currently GuruFocus does not have mailing address information for Su Zhou Gong Ye Yuan Qu Guan Wei Hui.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.